Pneumonia: all 2,072 studies

Page 8 of 21. Open to participants first (286), then studies with results posted, then the rest; newest registration first within each.

• Aiding COPD and CHF Ultrasound-guided Management Through ENhanced Point Of Care UltraSoundActive, not recruitingNCT05423652Not applicable
• Hospital Acquired Pneumonia in Temporary TracheostomyStatus unknownNCT05418517
• Effect of Kunamin in SARS-CoV-2 RT-PCR Positive Covid-19 PatientsCompletedNCT05417997Phase 3
• Effectiveness of Oral Management Strategies on Improving Oral Frailty and Oral BacteriaCompletedNCT05407532Not applicable
• Health Education to Caregivers to Reduce Aspiration PneumoniaCompletedNCT05405829Not applicable
• Effect of Prone Positioning on the Severity of COVID-19 Pneumonia and Acute Respiratory Distress Syndrome.CompletedNCT05405335Not applicable
• Cuff Pressure Control and Evacuation of Subglottic Secretions To Prevent PneumoniaCompletedNCT05403320Not applicable
• Study of Ingaron's Effect on Efficacy and Resistance to Antibiotics in Community-acquired PneumoniaCompletedNCT05395702Not applicable
• A Retrospective Study to Evaluate the Predictability of Abnormal Arterial Blood Gas Measurements Through Novel Observations of Continuous Trends in Electronically Measured Respiratory Rate in a Mixed Cohort of Respiratory Compromised PatientsStatus unknownNCT05384314
• Serotype Distribution in Hospitalized Adult With Pneumococcal Community Acquired Pneumonia in FranceCompletedNCT05380193
• Urinary Antigen Test for Stretococcus Pneumoniae Serotype Prevalence in Community Acquired PneumoniaActive, not recruitingNCT05374018
• A Controlled Human Pneumococcal Infection Model (PIM) StudyCompletedNCT05361499Not applicable
• Postural Drainage and PEP Technique in Community Acquired PneumoniaCompletedNCT05356494Not applicable
• HYDROcortisone Versus Placebo for Severe HospItal-acquired Pneumonia in Intensive Care Patients: the HYDRO-SHIP StudyCompletedNCT05354778Not applicable
• Phase 2b/3 Trial of NuSepin® in COVID-19 Pneumonia PatientsStatus unknownNCT05352347Phase 2/3
• Platelets in Cystic Fibrosis Lung InflammationCompletedNCT05339724
• Individualizing Corticosteroid Use in PneumoniaCompletedNCT05334316Phase 2
• A Human Monoclonal Antibody Against Staphylococcus Aureus Alpha Toxin in Mechanically Ventilated Adult Subjects - 2TerminatedNCT05331885Phase 3
• Tobacco Use and the Risk of COVID-19 and Adverse OutcomesCompletedNCT05321433
• Clinical Trial Scheme of Tanreqing Capsules in the Treatment of COVID-19CompletedNCT05305456Phase 3
• M-ROSE Combined With mNGS in Severe Hospital-acquired PneumoniaStatus unknownNCT05300776Not applicable
• mNGS -Guided Antimicrobial Treatment in Early Severe Community-Acquired Pneumonia Among Immunocompromised PatientsStatus unknownNCT05290454Not applicable
• Evaluation of Postmortem Pulmonary Interstitial Fibrosis Severity and EGFR Positivity in Covid-19 PneumoniaCompletedNCT05290441Not applicable
• Mesenchymal Stromal Cells for COVID-19 and Viral PneumoniasWithdrawnNCT05286255Phase 1
• Pirfenidone Combined With Methylprednisolone Versus Methylprednisolone in the Treatment of CIPStatus unknownNCT05280873Phase 1
• Effects of IMT on Functional Capacity in Patients With Chronic COVID After Hospital DischargeCompletedNCT05279430Not applicable
• The Effects of Heated Tobacco Products Use on Lung Function and Volatile Organic Compounds in Exhaled AirCompletedNCT05260827Not applicable
• Safety of Nebulized Combination Therapy BromAc® in COVID-19 Respiratory DiseaseStatus unknownNCT05258682Phase 1/2
• Low-Level Laser Therapy Treatment of Lung Inflammation in Post-COVID-19 RecoveryTerminatedNCT05258617
• Nebulised Heparin in Patients With COVID-19 PneumoniaStatus unknownNCT05255848Phase 2/3
• "Clinical Characteristics, Comorbidities and Outcome of Critically Sick Patients With COVID-19CompletedNCT05249803
• Health Communication to Influence COVID-19 Vaccination Intent and Message PropagationCompletedNCT05244356Not applicable
• Feasibility and Acceptability Followed by Effectiveness of bCPAP for Treatment of Bangladeshi Children With Severe PneumoniaCompletedNCT05239559
• Effect of Statin Therapy on Mortality in Patients With Ventilator Associated PneumoniaCompletedNCT05230472Phase 4
• Nebulised BromAc in Healthy VolunteersCompletedNCT05220605Phase 1
• The Effect of Deep Breathing and Cough Exercise on Respiratory Parameters in Patients With Covid-19 Associated PneumoniaStatus unknownNCT05218200Not applicable
• Effects of Recombinant Human Thrombopoietin on Platelet Levels in ICU PatientsStatus unknownNCT05217719Phase 4
• FilmArray Pneumonia Panel for Antimicrobial Treatment of HAP/VAP in Intensive Care UnitsTerminatedNCT05214716Not applicable
• Evaluate the Efficacy and Safety of TF0023 in Treatments for COVID-19 in Hospitalized AdultsTerminatedNCT05212818Phase 2
• Open Suction Circuit Flushing With Chlorhexidine Decreases Ventilator-Associated Pneumonia: A Quasi-experimental StudyCompletedNCT05206721Early Phase 1
• Simultaneously Implementing Pathways for Improving Asthma, Pneumonia, and Bronchiolitis Care for Hospitalized ChildrenCompletedNCT05206695Not applicable
• Study of F-652 in Subjects With Corona Virus Disease 2019 (COVID-19) PneumoniaWithdrawnNCT05205668Phase 2
• Delayed Antibiotic Therapy in Non-severe Ventilator Acquired Pneumonia (VAP)CompletedNCT05205525
• Early-initiated High Flow Oxygen Therapy vs Conventional Oxygen Therapy Among Patients With ARDS in the Course of SARS-CoV2 Pneumonia.Status unknownNCT05197686Not applicable
• Description of Lung Transplant Patients With Microbiologically Documented Stenotrophomonas Maltophilia Pneumonia and Impact of Treatment on OutcomeStatus unknownNCT05193058
• Oral Probiotics and Secondary Bacterial Pneumonia in Severe COVID-19CompletedNCT05175833Phase 2
• Prevalence and Serotype of Streptococcus Pneumoniae Hospitalized Adult With Community-Acquired PneumoniaCompletedNCT05173727
• Decreasing Unnecessary Antibiotics Prescribed for Possible Pneumonia Despite Normal Respiratory Rate and OxygenationCompletedNCT05172791Not applicable
• Dexmedetomidine Reduces Atrial Fibrillation in Mechanically Ventilated Patients With COVID-19 PneumoniaStatus unknownNCT05171985Not applicable
• A Placebo-Controlled Study of Auxora for the Extended Treatment of High- Risk Patients With Critical COVID-19 PneumoniaWithdrawnNCT05171920Phase 2
• Oral Care to Prevent Ventilator-associated PneumoniaCompletedNCT05161962Not applicable
• Effect of Covid 19 Infection on Fetomaternal OutcomeStatus unknownNCT05160649
• Treatment of COVID-19 Positive/Negative Bangladeshi Adults With Severe Respiratory Complaints by a Locally Made bCPAP: Feasibility StudyCompletedNCT05158842Not applicable
• The Validity of the ROX Index in Predicting Intubation in Patients With Covid-19 PneumoniaCompletedNCT05150886
• The Diagnosis of Superinfections in Mechanically Ventilated Covid-19 PatientsStatus unknownNCT05148975
• The Relationship Between Hormone Sensitivity and Imaging of Idiopathic Interstitial Pneumonia by Artificial IntelligenceCompletedNCT05146934
• Study of Pulmonary Infections (Pneumonia) in Kidney Transplant Recipients Admitted to HospitalCompletedNCT05142748
• Assess the Safety and Immunogenicity of PNEUMOSIL® Vaccine in Healthy Vietnamese Children, 6 Weeks to 24 Months of AgeStatus unknownNCT05140720Not applicable
• Efficiency of the Imaging Strategy for the Management of PneumoniaStatus unknownNCT05140408
• High-flow Nasal Oxygenation and Non-invasive Ventilation Strategies for the Treatment of Covid-19 PneumoniaCompletedNCT05137431
• Unrefined Salmon Oil as Dietary Supplement in Adult AsthmaticsCompletedNCT05137132Not applicable
• SP16 as a Therapeutic for COVID-19 Induced ARDSTerminatedNCT05135624Phase 1
• Oral Nemonoxacin in Treating Elderly Patients With CAPCompletedNCT05133752Phase 4
• Mesenchymal Stem Cells for the Treatment of Pneumonia Post Haematopoietic Stem Cell TransplantationCompletedNCT05131412
• Phase 2a Multiple Ascending Dose Study in Hospitalized Patients With Pneumonia.Active, not recruitingNCT05123755Phase 2
• Adding Colchicine to Tocilizumab in Patients With Severe COVID-19 Pneumonia.Status unknownNCT05118737Early Phase 1
• Vaccination Perception in Inflammatory Conditions - Flu, Pneumonia and COVID-19CompletedNCT05115370
• PCV13 Impact on Pneumococcal Nasopharyngeal Carriage StudyActive, not recruitingNCT05114902
• Promoting Optimal Treatment for Community-acquired Pneumonia in the Emergency Room (PIONEER)CompletedNCT05114161Not applicable
• Artificial Intelligence in Diagnosing Dysphagia PatientsCompletedNCT05098808
• Cutaneous Manifestations of Coronavirus Disease 2019(COVID-19).CompletedNCT05094687
• Predictors of Non-invasive Respiratory Support Failure in COVID-19 PneumoniaCompletedNCT05094661Not applicable
• Influence of Pneumonia on Delayed Cerebral Ischemia After Subarachnoid Hemorrhage . SAH-CIP (SubArrachnoid Hemorrhage - Cerebral Infarction Pneumonia)CompletedNCT05094349
• Clinical Presentations and Outcomes of Patients With Covid-19 PneumoniaStatus unknownNCT05092555
• Ventilation Associated Pneumonia and Covid-19CompletedNCT05089968
• Prognostic Value Of Chest Ultrasound (Lung Ultrasound Score) In COVID-19 Pneumonia PatientsStatus unknownNCT05080257
• Evaluation of Immunogenicity and Safety of Combined Immunization of COVAX (Produced in Wuhan) and PPV23 / IIV4Status unknownNCT05079152Phase 4
• Cromolyn Sodium for Treatment of COVID-19 PneumoniaTerminatedNCT05077917Phase 3
• A Case-control Study on Risk Factors, Timing, and PCR Use, for Pneumocystis Pneumonia (PcP) After Allogeneic HSCTCompletedNCT05077150
• FilmArray® and Management of Ventilator Associated Pneumonia in COVID-19 ARDSCompletedNCT05076240
• Mobile Integrated Healthcare and Community ParamedicineStatus unknownNCT05061433Not applicable
• HOspital NEtwork STudy - Preparation for a Randomized Evaluation of Anti-Pneumonia StrategiesCompletedNCT05060718
• Tocilizumab in Covid-19 Penumonia in Buenos Aires CityCompletedNCT05057962
• Baseline Blood Indices and Prolonged Length of Hospital StayStatus unknownNCT05054283
• Nutritional Parameters and Other Risk Factors Affecting Severity of Pneumonia in Children Under Five Years in Upper EgyptStatus unknownNCT05050851
• Validation of a CDSA Strategy to Reduce Antibiotic Prescription in SenegalCompletedNCT05050825Not applicable
• Study to Evaluate the Dynamic Consent Model Based on the Blockchain-based Clinical Trial Platform METORYStatus unknownNCT05047016Not applicable
• The Effect of Tocilizumab on Procalcitonin and Other Biochemical and Clinical Markers in the Setting of COVID-19 PneumoniaCompletedNCT05035589
• Steroid and Anticoagulant Therapy in covid19CompletedNCT05021588Not applicable
• Diaphragm Ultrasound Evaluation During Weaning From Mechanical Ventilation in the Positive COVID-19 PatientStatus unknownNCT05019313
• A Pre-post Intervention Study Evaluating Home-based Management of Patients With COPD or CAPWithdrawnNCT05009485Not applicable
• Efficacy of the Early Prone-positioning in Hospitalized Patients With Mild Covid-19 PneumoniaCompletedNCT05008380Not applicable
• The Effectiveness of Respiratory Tele-rehabilitation After COVID-19 Pneumonia Related: a Randomized Controlled TrialStatus unknownNCT05007457Not applicable
• Effect of Preoperative Oral Carbohydrate Administration in Thoracic Surgery PatientsCompletedNCT05005091Not applicable
• Randomized, Unicentric, Open, Controlled Clinical Trial, in Phase Iii, to Demonstrate the Effectiveness of TocilizumabStatus unknownNCT05002517Phase 3
• A Retrospective, Real-world Study of ELP Used in the Expectorant Treatment of Community-acquired PneumoniaStatus unknownNCT05002192
• Practice Variation on Antithrombotics in COVID-19CompletedNCT04998799
• Pain, Fatigue and Life Quality in COVID-19 PatientsStatus unknownNCT04988126
• PNEUmonia DOSing in Critically Ill Patients (PNEUDOS)CompletedNCT04986254
• CT Scan Compared to CXR and LUS in Pneumonia in the ElderlyCompletedNCT04978116Not applicable

← Pneumonia overview